LCS12 adolescent study

Registry ID

EUCTR2011-002065-37

Source registry

EUCTR

Status

Completed

Phase

PHASE3

Sponsor

Bayer HealthCare AG

Start date

2011-08-30

Last update

2026-08-16

Conditions

• Contraception

Summary

The primary objective is to assess the safety of low-dose levonorgestrel (LNG) (12μg/24h, initial in vitro release rate), delivered locally by an intrauterine contraceptive system in adolescents over 1 year of treatment, including insertion and removal procedures.

Locations

• , , Finland
• , , Norway
• , , Netherlands
• , , Austria
• , , Belgium
• , , Denmark
• , , Germany
• , , Sweden

Related clinical trials

• Etonogestrel Implant as Emergency Contraception
• Long Term Evaluation of Scapular-inserted Contraceptive Implants
• Trial of the "Mittin" Intervention to Improve Contraceptive Side Effect Counseling and Follow-up in Ethiopia
• "Vasectomy: Right for Me?" Decision Support Tool
• Oral Contraceptive Pill (OCP) Pharmacogenomics
• Validation of Effectiveness on NaturalCycles Users

View on source registry